A detailed history of Peak6 LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Peak6 LLC holds 238,300 shares of BMY stock, worth $13 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
238,300
Holding current value
$13 Million
% of portfolio
0.03%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
$51.92 - $59.94 $785,341 - $906,652
15,126 New
15,126 $855,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $116B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Peak6 LLC Portfolio

Follow Peak6 LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 LLC with notifications on news.